Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR)
The Committee provides opinions on emerging or newly-identified health and environmental risks and on broad, complex or multidisciplinary issues requiring a comprehensive assessment of risks to consumer safety or public health and related issues not covered by other Community risk assessment bodies.
Potential areas of activity include:
- antimicrobial resistance
- new technologies (e.g. nanotechnologies)
- medical devices including those incorporating substances of animal/human origin
- physical hazards (e.g. noise, electromagnetic fields)
- tissue engineering
- blood products
- fertility reduction
- cancer of endocrine organs
- interaction of risk factors, synergic effects, cumulative effects
- methodologies for assessing new risks
It may also be invited to address risks related to public health determinants and non-transmissible diseases.
• Members can be contacted via the Secretariat.
The committee usually produces its reports in response to a specific request.
Opinions and statements
At the end of the risk assessment process, the Committee adopts opinions. The Committee can also, at its own initiative, publish statements on specific topics.
Opinions in plain language
For some opinions – of direct relevance to the public – a plain-language version is produced for non-specialists.
• Agenda and minutes of working group meetings
• Rules of procedure of the Scientific Committees
• the stakeholder dialogue procedure is set out in Annex IV of that document.
SANTE-C2-SCHEER AT ec.europa.eu
Former Scientific Committees